Testosterone Cypionate for Women
by Anthony Roberts
Anabolic steroid use by females is a controversial subject, despite their enormous value. The argument is often made that females have no business taking male hormones – a spurious argument at best, considering some steroids (Deca, for example) are derived from female hormones, namely progesterone, and not testosterone per se. Most people would be shocked to find out that most of the figure and fitness girls in the mainstream magazines have done a cycle or three. Still, the controversy remains, due in no small part to the highly visible side-effects seen in the professional ranks of women’s bodybuilding.
And the most controversial of the hormones used by women is, of course, testosterone. But a recent study has indicated that a single monthly injection of 100mgs of testosterone cypionate can be effective for increasing libido, without causing undue side effects (far too low to even be a competitive cycle for an amateur female bodybuilder in the NPC). This is a reasonably low dose (25mgs/week), but I’m left wondering why they didn’t try using a milder anabolic, as those are well-known for increasing libido in women as well…
sourcePotential role of androgens in the treatment of hypoactive sexual desire in women.
University of Virginia, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA, USA. firstname.lastname@example.org.
Photo courtesy of World Pharma
Evaluation of: van Anders SM, Chernick AB, Chernick BA et al.: Preliminary clinical experience with androgen administration for pre- and postmenopausal women with hypoactive sexual desire. J. Sex Marital Ther. 31, 173-185 (2005). There has been significant debate about the potential role of androgens in the treatment of hypoactive sexual desire in women. In this study, pre- and postmenopausal women with hypoactive sexual desire were age-matched with women without such complaints (n = 33). The treatment group received 100 mg of testosterone cypionate intramuscularly once a month for 3 months. Measures of salivary testosterone indicated no difference between groups at baseline, with an increase in testosterone levels in the hypoactive sexual desire group post-treatment. While significant differences existed between the two groups at baseline in scores on the Sexual Desire Inventory, the treated women demonstrated a significant increase in sexual desire post-treatment, with no difference in Sexual Desire Inventory scores at study end point. This study suggests that supplemental testosterone may improve sexual desire in women with hypoactive sexual desire without hypoandrogenism.
[PubMed - in process]